Trial Profile
Twice Daily Prevacid for the Treatment of Laryngopharyngeal Reflux: A Double-Blind, Placebo Controlled, Randomized Clinical Trial.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 30 Mar 2017
Price :
$35
*
At a glance
- Drugs Lansoprazole (Primary)
- Indications Laryngopharyngeal reflux
- Focus Therapeutic Use
- 25 Mar 2009 New trial record